PharmaShots | Incisive News in 3 Shots

Subscribe Now

Active Biotech

Active Biotech’ Tasquinimod Receives the US FDA’s Orphan Drug Designation for the Treatment of Myelofibrosis

Active Biotech’ Tasquinimod Receives the US FDA’s Orphan Drug Designation for the Treatment of Myelofibrosis

May 19, 2022

Active Biotech Reports First Patient Dosing in the P-Ib/IIa Study of Tasquinimod for the Treatment of Multiple Myeloma

Active Biotech Reports First Patient Dosing in the P-Ib/IIa Study of Tasquinimod for the Treatment of Multiple Myeloma

February 7, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us